First Horizon Advisors’s Acceleron Pharma XLRN Stock Holding History

First Horizon Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-353	Closed	-$59K	–	2509
2021 Q3	$59K	Buy	353 +15	+4%	+$1.96K	﹤0.01%	838
2021 Q2	$42K	Sell	338 -67	-17%	-$8.45K	﹤0.01%	852
2021 Q1	$54K	Hold	405	–	–	﹤0.01%	715
2020 Q4	$51K	Buy	405 +14	+4%	+$1.64K	﹤0.01%	598
2020 Q3	$43K	Buy	+391	New	+$38.9K	﹤0.01%	587

First Horizon Advisors's XLRN Position: Q4 2021 in Review

First Horizon Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 353 shares — an estimated $59K sold.

First Horizon Advisors first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $59K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

First Horizon Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
First Horizon Advisors sold 353 Acceleron Pharma shares in Q4 2021, an estimated $59K.
First Horizon Advisors first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
First Horizon Advisors's Acceleron Pharma position peaked at $59K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on First Horizon Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.